SCHEMBL26291340

SCHEMBL26291340

COC(=O)c1ccc(OC(F)F)c(C(F)(F)F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.56
MRGPRX4 Q96LA9 1/20 0.47
CYP3A4 P08684 1/20 0.45
ESRRA P11474 1/20 0.45
EPHX2 P34913 1/20 0.44
P4HB P07237 1/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 2/20 0.43
HTT P42858 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
XDH P47989 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16761991 0.88 NOTUM (0.60) NOTUMMRGPRX4EPHX2P4HBMAPT
SCHEMBL24860963 0.88 NOTUM (0.60) NOTUMMRGPRX4CYP3A4ESRRAP4HB
SCHEMBL10310530 0.86 NOTUM (0.54) NOTUMMRGPRX4CYP3A4ESRRAP4HB
SCHEMBL17386552 0.85 SCN9A (0.45) EPHX2MAPTKDM4EHTTLMNA
SCHEMBL10088903 0.85 NOTUM (0.52) NOTUMMRGPRX4CYP3A4ESRRAP4HB
SCHEMBL2470879 0.84 NOTUM (0.62) NOTUMMRGPRX4CYP3A4ESRRAP4HB
SCHEMBL28035311 0.81 THRA (0.46) EPHX2MAPTKDM4EHTTKMT2A
SCHEMBL3738587 0.80 MAPT (0.64) CYP3A4MAPTKDM4EHTTL3MBTL1
SCHEMBL22954276 0.80 MAPT (0.64) CYP3A4MAPTKDM4EHTTL3MBTL1
SCHEMBL29723267 0.80 CA12 (0.59) P4HBMAPTKDM4EHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295076-A1 ACETOPHENONE OXIME COMPOUND AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-09-21 US disclosed
US-20230295076-A1 ACETOPHENONE OXIME COMPOUND AND APPLICATION THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295076-A1 ACETOPHENONE OXIME COMPOUND AND APPLICATION THEREOF CYP11B2, ALDH7A1, CYP11B1 NOTUM 95/4885MRGPRX4 4794/4885CYP3A4 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.